Atlas Trials

Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration

Clinical trial NCT00845273 · COMPLETED

Trial details

NCT number
NCT00845273
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Macular Degeneration
Start date
2008-11-01
Primary completion
2014-02-01
Enrollment
3538

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.